Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
Public ClinicalTrials.gov record NCT00646958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Open-Label, Comparative Study to Evaluate the Safety and Efficacy of RX-1741 Versus Linezolid in the Outpatient Treatment of Adult Patients With Uncomplicated Skin and Skin Structure Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections
Study identification
- NCT ID
- NCT00646958
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2007 (Type not available)
- Primary completion
- Apr 2008 (Actual)
- Completion
- Apr 2008 (Actual)
- Last update posted
- Mar 27, 2014
2007 – 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Drug Research & Analysis Corp | Montgomery | Alabama | — | — |
| OWENS Pharma Research Center | Long Beach | California | — | — |
| Healthcare Partners Medical Group | Los Angeles | California | — | — |
| HealthCare Partners Medical Group | Pasadena | California | — | — |
| Olive View- UCLA Center, Dept. Emergency Medicine | Sylmar | California | — | — |
| South Florida Clinical Research | Atlantis | Florida | — | — |
| Southeast Regional Research Group | Columbus | Georgia | — | — |
| Contemporary Medicine, LLC | Hinesville | Georgia | — | — |
| Infectious Disease of Indiana, PSC. | Indianapolis | Indiana | — | — |
| Clinical Trials of America, Inc. | Shreveport | Louisiana | — | — |
| Arnold Markowitz, MD., PC | Keego Harbor | Michigan | — | — |
| Mercury Street Medical Group, LLC | Butte | Montana | — | — |
| Jamaica Hospital Medical Center | Jamaica | New York | — | — |
| ALL-TRIALS Clinical Research, LLC | Winston-Salem | North Carolina | — | — |
| Summa Health System | Akron | Ohio | — | — |
| Brandywine Clinical Research | Downington | Pennsylvania | — | — |
| Warminster Medical Associates, P.C. | Warminster | Pennsylvania | — | — |
| McKenzie Medical Center | McKenzie | Tennessee | — | — |
| J. Lewis Research, Inc. | Salt Lake City | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00646958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2014 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00646958 live on ClinicalTrials.gov.